DOMINIC ANTONIO ATIYEH

Allopathic & Osteopathic Physicians|Family Medicine CLAWSON, MI NPI 1306368527

General Payments — all program years on this page

$3,417.72

  • Category: General Payments
  • Program years: PY2019–2023
  • Record count: 192
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $748.11 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $748.1141

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $18.091
2020 $302.3318
2021 $1,693.6893
2022 $655.5139
2023 $748.1141

Records — PY2023 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1001625279 GlaxoSmithKline, LLC. $13.95 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001625291 GlaxoSmithKline, LLC. $1.60 08/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001625303 GlaxoSmithKline, LLC. $28.28 08/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001625313 GlaxoSmithKline, LLC. $20.09 06/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001625325 GlaxoSmithKline, LLC. $12.36 02/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001625337 GlaxoSmithKline, LLC. $52.60 04/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411639 Novo Nordisk Inc $6.65 03/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411651 Novo Nordisk Inc $9.17 03/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411663 Novo Nordisk Inc $11.06 02/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411675 Novo Nordisk Inc $14.32 06/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411687 Novo Nordisk Inc $15.01 05/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411699 Novo Nordisk Inc $15.13 09/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411711 Novo Nordisk Inc $15.22 02/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411723 Novo Nordisk Inc $15.86 09/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411735 Novo Nordisk Inc $16.23 01/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411747 Novo Nordisk Inc $16.28 03/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411759 Novo Nordisk Inc $16.77 01/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411771 Novo Nordisk Inc $19.27 05/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002411783 Novo Nordisk Inc $23.77 08/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014265263 AstraZeneca Pharmaceuticals LP $14.33 01/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014665537 AstraZeneca Pharmaceuticals LP $13.82 05/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015650985 AstraZeneca Pharmaceuticals LP $15.17 06/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015706293 AstraZeneca Pharmaceuticals LP $14.08 07/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034251173 Astellas Pharma US Inc $13.81 07/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049165235 PFIZER INC. $16.38 04/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049620007 PFIZER INC. $24.36 02/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049815929 PFIZER INC. $16.20 08/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050732207 Esperion Therapeutics, Inc. $21.45 08/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1055338253 Takeda Pharmaceuticals U.S.A., Inc. $23.85 02/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1055338257 Takeda Pharmaceuticals U.S.A., Inc. $15.02 08/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057773569 Inari Medical, Inc. $14.86 10/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174395 AbbVie Inc. $17.64 02/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174397 AbbVie Inc. $9.88 02/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174399 AbbVie Inc. $14.86 02/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174401 AbbVie Inc. $33.91 02/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174403 AbbVie Inc. $31.81 03/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174405 AbbVie Inc. $11.12 03/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174407 AbbVie Inc. $30.60 05/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996174409 AbbVie Inc. $22.07 06/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996689343 Boehringer Ingelheim Pharmaceuticals, Inc. $27.99 08/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996689351 Boehringer Ingelheim Pharmaceuticals, Inc. $21.28 01/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.